Boiron SA
Research Boiron SA (BOI) on Bullrun: market cap EUR 453.16M, P/E 13.9, dividend yield 5.3%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerBOI
- ExchangePA
- CountryFrance
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyEUR
- Market capEUR 453.16M
- P/E13.9
- Dividend yield5.3%
- Financial periodFY2025
- RevenueEUR 501.11M
- Revenue growth2.8%
- Net incomeEUR 32.64M
- Free cash flowEUR 29.72M
- Gross margin73.0%
Valuation Snapshot
latest market cap is EUR 453.16M; P/E is 13.9; dividend yield is 5.3%.
Peer valuation comparison
Latest P/E is 13.88x versus a Healthcare sector median of 24.46x (43.3% below).
Latest dividend yield is 5.34% versus a Healthcare sector median of 2.11% (153.1% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | EUR 501.11M | EUR 32.64M | EUR 29.72M | 73.0% | 1.88 | EUR 79.34M | EUR 31.48M | EUR 392.76M |
| FY2024 | EUR 487.56M | EUR 11.34M | EUR 23.60M | 73.6% | 0.65 | EUR 64.71M | EUR 14.97M | EUR 378.15M |
| FY2023 | EUR 493.25M | EUR 35.83M | EUR 27.47M | 72.6% | 2.06 | EUR 74.04M | EUR 13.70M | EUR 393.66M |
| FY2022 | EUR 534.24M | EUR 44.67M | EUR 40.10M | 71.1% | 2.57 | EUR 250.95M | EUR 22.17M | EUR 557.62M |
| FY2021 | EUR 455.20M | EUR 28.56M | EUR 22.33M | 72.0% | 1.63 | EUR 234.50M | EUR 3.66M | EUR 531.74M |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-24 | EUR 453.16M | 13.9 | 5.2% | 1.35 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 1.35 EUR, yield 5.3%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.2 EUR |
| FY2024 | 1.35 EUR |
| FY2023 | 11.46 EUR |
| FY2022 | 0.95 EUR |
| FY2021 | 0.95 EUR |
About Boiron SA
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices (in vitro diagnostics), dietary supplements, herbal remedies, cosmetics, and CBD-based products. It also provides homeopathic specialties comprising Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Boiron SA's market cap?
Boiron SA's market capitalization is EUR 453.16M.
What is Boiron SA's P/E ratio?
Boiron SA's price-to-earnings (P/E) ratio is 13.9.
Does Boiron SA pay a dividend?
Boiron SA has a dividend yield of 5.3%.
What does Boiron SA do?
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices (in vitro diagnostics), dietary supplements, herbal remedies, cosmetics, and CBD-based products.